Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis

Cell and Tissue Research

Volumn 349, Issue 2, 2012, Pages 433-446

  Stancu, Camelia S ^a   Toma, Laura ^a   Sima, Anca V ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

Author keywords

Endothelial dysfunction; HDL; Inflammation; LDL; Oxidative stress

Indexed keywords

AMLODIPINE; CHEMOKINE; DYSFUNCTIONAL HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NICOTINIC ACID; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER RECEPTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; CYTOKINE; LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CELL DAMAGE; CELL JUNCTION; CELL MIGRATION; CYTOKINE RELEASE; DISEASE COURSE; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FOAM CELL; GLYCOCALYX; HUMAN; HYPERLIPIDEMIA; NONHUMAN; OXIDATION; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN TRANSPORT; REVIEW; THROMBOSIS; UPREGULATION; ANIMAL; BLOOD; IMMUNOLOGY; METABOLISM; OXIDATIVE STRESS; PATHOLOGY;

ANIMALS; ATHEROSCLEROSIS; CYTOKINES; ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS; OXIDATIVE STRESS;

EID: 84871891225     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-012-1437-1     Document Type: Review

References (127)

1. Alipour A, Elte JW, van Zaanen HC, Rietveld AP, Castro Cabezas M (2008) Novel aspects of postprandial lipemia in relation to atherosclerosis. Atheroscler Suppl 9:39-44
2. Apostolov EO, Shah SV, Ok E, Basnakian AG (2007) Carbamylated low-density lipoprotein induces monocyte adhesion to endothelial cells through intercellular adhesion molecule-1 and vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol 27:826-832
3. Argraves KM, Argraves WS (2007) HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects. J Lipid Res 48:2325-2333
4. Badimon L, Vilahur G, Padro T (2009) Lipoproteins, platelets and atherothrombosis. Rev Esp Cardiol 62:1161-1178
5. Bauer V, Sotnikova R (2010) Nitric oxidethe endothelium-derived relaxing factor and its role in endothelial functions. Gen Physiol Biophys 29:319-340
6. Berliner JA, Gharavi NM (2008) Endothelial cell regulation by phospholipid oxidation products. Free Radic Biol Med 45:119-123
7. Besler C, Heinrich K, Riwanto M, Luscher TF, Landmesser U (2010) High-density lipoprotein-mediated anti-atherosclerotic and endothelial- protective effects: a potential novel therapeutic target in cardiovascular disease. Curr Pharm Des 16:1480-1493
8. Besler C, Heinrich K, Rohrer L, Doerries C, Riwanto M, Shih DM, Chroni A, Yonekawa K, Stein S, Schaefer N, Mueller M, Akhmedov A, Daniil G, Manes C, Templin C, Wyss C, Maier W, Tanner FC, Matter CM, Corti R, Furlong C, Lusis AJ, von Eckardstein A, Fogelman AM, Luscher TF, Landmesser U (2011) Mechanisms underlying adverse effects of HDL on eNOSactivating pathways in patients with coronary artery disease. J Clin Invest 121:2693-2708
9. Bishop JR, Passos-Bueno MR, Fong L, Stanford KI, Gonzales JC, Yeh E, Young SG, Bensadoun A, Witztum JL, Esko JD, Moulton KS (2010) Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans. PLoS One 5:e13919
10. Brandes RP, Schroder K (2008) Differential vascular functions of Nox family NADPH oxidases. Curr Opin Lipidol 19:513-518
11. Brown JD, Plutzky J (2007) Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Circulation 115:518-533
12. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350:1495-1504
13. Chadjichristos CE, Kwak BR (2007) Connexins: new genes in atherosclerosis. Ann Med 39:402-411
14. Chen K, Li W, Major J, Rahaman SO, Febbraio M, Silverstein RL (2011) Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state. Blood 117:5744-5750
15. Constantinescu A, Spaan JA, Arkenbout EK, Vink H, Vanteeffelen JW (2011) Degradation of the endothelial glycocalyx is associated with chylomicron leakage in mouse cremaster muscle microcirculation. Thromb Haemost 105:790-801
16. De Caterina R, Massaro M, Libby P (2007) Endothelial functions and dysfunctions. In: De Caterina R, Libby P (eds) Endothelial dysfunctions in vascular disease. Blackwell, Oxford. doi:10.1002/9780470988473.ch1
17. Dejana E, Orsenigo F, Molendini C, Baluk P, McDonald DM (2009) Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res 335:17-25
18. Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodes-Cabau J, Bertrand OF, Poirier P (2008) Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28:1039-1049
19. Dong Y, Wu Y, Wu M, Wang S, Zhang J, Xie Z, Xu J, Song P, Wilson K, Zhao Z, Lyons T, Zou MH (2009) Activation of protease calpain by oxidized and glycated LDL increases the degradation of endothelial nitric oxide synthase. J Cell Mol Med 13:2899-2910
20. Dong Y, Zhang M, Wang S, Liang B, Zhao Z, Liu C, Wu M, Choi HC, Lyons TJ, Zou MH (2010) Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo. Diabetes 59:1386-1396
21. Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker JH, Ponnambalam S (2008) The lectin-like oxidized low-densitylipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J 409:349-355
22. Dworakowski R, Alom-Ruiz SP, Shah AM (2008) NADPH oxidasederived reactive oxygen species in the regulation of endothelial phenotype. Pharmacol Rep 60:21-28
23. Eiselein L, Wilson DW, Lame MW, Rutledge JC (2007) Lipolysis products from triglyceride-rich lipoproteins increase endothelial permeability, perturb zonula occludens-1 and F-actin, and induce apoptosis. Am J Physiol Heart Circ Physiol 292:H2745-H2753
24. Engin F, Hotamisligil GS (2010) Restoring endoplasmic reticulum function by chemical chaperones: an emerging therapeutic approach for metabolic diseases. Diabetes Obes Metab 12(Suppl 2):108-115
25. Farmer JA, Liao J (2011) Evolving concepts of the role of high-density lipoprotein in protection from atherosclerosis. Curr Atheroscler Rep 13:107-114
26. Ganji SH, Qin S, Zhang L, Kamanna VS, Kashyap ML (2009) Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells. Atherosclerosis 202:68-75
27. Gargalovic PS, Gharavi NM, Clark MJ, Pagnon J, Yang WP, He A, Truong A, Baruch-Oren T, Berliner JA, Kirchgessner TG, Lusis AJ (2006) The unfolded protein response is an important regulator of inflammatory genes in endothelial cells. Arterioscler Thromb Vasc Biol 26:2490-2496
28. Gargalovic PS, Erbilgin A, Kohannim O, Pagnon J, Wang X, Castellani L, LeBoeuf R, Peterson ML, Spear BT, Lusis AJ (2010) Quantitative trait locus mapping and identification of Zhx2 as a novel regulator of plasma lipid metabolism. Circ Cardiovasc Genet 3:60-67
29. Goettsch C, Goettsch W, Muller G, Seebach J, Schnittler HJ, Morawietz H (2009) Nox4 overexpression activates reactive oxygen species and p38 MAPK in human endothelial cells. Biochem Biophys Res Commun 380:355-360
30. Hansson GK, Hermansson A (2011) The immune system in atherosclerosis. Nat Immunol 12:204-212
31. Harats D, Shaish A, George J, Mulkins M, Kurihara H, Levkovitz H, Sigal E (2000) Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptordeficient mice. Arterioscler Thromb Vasc Biol 20:2100-2105
32. Hashimoto K, Kataoka N, Nakamura E, Tsujioka K, Kajiya F (2007) Oxidized LDL specifically promotes the initiation of monocyte invasion during transendothelial migration with upregulated PECAM-1 and downregulated VE-cadherin on endothelial junctions. Atherosclerosis 194:e9-e17
33. Hedrick CC, Thorpe SR, Fu MX, Harper CM, Yoo J, Kim SM, Wong H, Peters AL (2000) Glycation impairs high-density lipoprotein function. Diabetologia 43:312-320
34. Heltianu C, Robciuc A, Botez G, Musina C, Stancu C, Sima AV, Simionescu M (2011) Modified low density lipoproteins decrease the activity and expression of lysosomal Acid lipase in human endothelial and smooth muscle cells. Cell Biochem Biophys 61:209-216
35. Hennig B, Shasby DM, Spector AA (1985) Exposure to fatty acid increases human low density lipoprotein transfer across cultured endothelial monolayers. Circ Res 57:776-780
36. Horke S, Witte I, Wilgenbus P, Kruger M, Strand D, Forstermann U (2007) Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation. Circulation 115:2055-2064
37. Hotamisligil GS (2010) Endoplasmic reticulum stress and atherosclerosis. Nat Med 16:396-399
38. Izzo JL Jr, Purkayastha D, Hall D, Hilkert RJ (2010) Comparative efficacy and safety of amlodipine/benazepril combination therapy and amlodipine monotherapy in severe hypertension. J Hum Hypertens 24:403-409
39. Jiang WG, Bryce RP, Horrobin DF, Mansel RE (1998) Regulation of tight junction permeability and occludin expression by polyunsaturated fatty acids. Biochem Biophys Res Commun 244:414-420
40. Jun M, Foote C, Lv J, Neal B, Patel A, Nicholls SJ, Grobbee DE, Cass A, Chalmers J, Perkovic V (2010) Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet 375:1875-1884
41. Kang BY, Wang W, Palade P, Sharma SG, Mehta JL (2009) Cardiac hypertrophy during hypercholesterolemia and its amelioration with rosuvastatin and amlodipine. J Cardiovasc Pharmacol 54:327-334
42. Kobayashi Y (2010) The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. J Leukoc Biol 88:1157-1162
43. Kuo MY, Ou HC, Lee WJ, Kuo WW, Hwang LL, Song TY, Huang CY, Chiu TH, Tsai KL, Tsai CS, Sheu WH (2011) Ellagic acid inhibits oxidized low-density lipoprotein (OxLDL)-induced metalloproteinase (MMP) expression by modulating the protein kinase Calpha/extracellular signal-regulated kinase/peroxisome proliferator-activated receptor gamma/nuclear factor-kappaB (PKC-alpha/ERK/PPAR- gamma/NF-kappaB) signaling pathway in endothelial cells. J Agric Food Chem 59:5100-5108
44. Lee S, Gharavi NM, Honda H, Chang I, Kim B, Jen N, Li R, Zimman A, Berliner JA (2009) A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids. Free Radic Biol Med 47:145-151
45. Lee MH, Hammad SM, Semler AJ, Luttrell LM, Lopes-Virella MF, Klein RL (2010) HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1- phosphate. J Lipid Res 51:2619-2628
46. Li D, Liu L, Chen H, Sawamura T, Mehta JL (2003) LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 23:816-821
47. Libby P (2005) The forgotten majority: unfinished business in cardiovascular risk reduction. J Am Coll Cardiol 46:1225-1228
48. Libby P, Ridker PM, Hansson GK (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473:317-325
49. Lubos E, Handy DE, Loscalzo J (2008) Role of oxidative stress and nitric oxide in atherothrombosis. Front Biosci 13:5323-5344
50. Marschang P, Gotsch C, Kirchmair R, Kaser S, Kahler CM, Patsch JR (2006) Postprandial, but not postabsorptive low-density lipoproteins increase the expression of intercellular adhesion molecule-1 in human aortic endothelial cells. Atherosclerosis 186:101-106
51. Marsche G, Levak-Frank S, Quehenberger O, Heller R, Sattler W, Malle E (2001) Identification of the human analog of SR-BI and LOX-1 as receptors for hypochlorite-modified high density lipoprotein on human umbilical venous endothelial cells. FASEB J 15:1095-1097
52. Mastorikou M, Mackness B, Liu Y, Mackness M (2008) Glycation of paraoxonase-1 inhibits its activity and impairs the ability of highdensity lipoprotein to metabolize membrane lipid hydroperoxides. Diabet Med 25:1049-1055
53. Mattaliano MD, Huard C, Cao W, Hill AA, Zhong W, Martinez RV, Harnish DC, Paulsen JE, Shih HH (2009) LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells. Am J Physiol Cell Physiol 296: C1329-C1337
54. Mattaliano MD, Wooters J, Shih HH, Paulsen JE (2010) ROCK2 associates with lectin-like oxidized LDL receptor-1 and mediates oxidized LDL-induced IL-8 production. Am J Physiol Cell Physiol 298:C1180-C1187
55. Maziere C, Maziere JC (2009) Activation of transcription factors and gene expression by oxidized low-density lipoprotein. Free Radic Biol Med 46:127-137
56. McAllister RM, Morris DM, Weimer CM, Laughlin MH (2010) Effects of high-density lipoprotein on endothelium-dependent vasorelaxation. Appl Physiol Nutr Metab 35:319-327
57. Mehta D, Malik AB (2006) Signaling mechanisms regulating endothelial permeability. Physiol Rev 86:279-367
58. Michel T, Vanhoutte PM (2010) Cellular signaling and NO production. Pflugers Arch 459:807-816
59. Miller AM (2011) Role of IL-33 in inflammation and disease. J Inflamm (Lond) 8:22
60. Mineo C, Deguchi H, Griffin JH, Shaul PW (2006) Endothelial and antithrombotic actions of HDL. Circ Res 98:1352-1364
61. Mompeo B, Popov D, Sima A, Constantinescu E, Simionescu M (1998) Diabetes-induced structural changes of venous and arterial endothelium and smooth muscle cells. J Submicrosc Cytol Pathol 30:475-484
62. Moore KJ, Freeman MW (2006) Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 26:1702-1711
63. Moore KJ, El Khoury J, Medeiros LA, Terada K, Geula C, Luster AD, Freeman MW (2002) A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J Biol Chem 277:47373-47379
64. Muller C, Salvayre R, Negre-Salvayre A, Vindis C (2010) HDLs inhibit endoplasmic reticulum stress and autophagic response induced by oxidized LDLs. Cell Death Differ 18:817-828
65. Navab M, Imes SS, Hama SY, Hough GP, Ross LA, Bork RW, Valente AJ, Berliner JA, Drinkwater DC, Laks H et al (1991) Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 88:2039-2046
66. Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, Reddy ST, Sevanian A, Fonarow GC, Fogelman AM (2000) Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res 41:1495-1508
67. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Fogelman AM (2009) HDL as a biomarker, potential therapeutic target, and therapy. Diabetes 58:2711-2717
68. Navarra T, Del Turco S, Berti S, Basta G (2009) The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: cardiovascular implications. J Atheroscler Thromb 17:317-331
69. Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, Chapple S, Cohen G, Feher J, Grune T, Lengyel G, Mann GE, Pamplona R, Poli G, Portero-Otin M, Riahi Y, Salvayre R, Sasson S, Serrano J, Shamni O, Siems W, Siow RC, Wiswedel I, Zarkovic K, Zarkovic N (2010) Pathological aspects of lipid peroxidation. Free Radic Res 44:1125-1171
70. Nicholls SJ, Cutri B, Worthley SG, Kee P, Rye KA, Bao S, Barter PJ (2005a) Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 25:2416-2421
71. Nicholls SJ, Zheng L, Hazen SL (2005b) Formation of dysfunctional high-density lipoprotein by myeloperoxidase. Trends Cardiovasc Med 15:212-219
72. Nicholls SJ, Lundman P, Harmer JA, Cutri B, Griffiths KA, Rye KA, Barter PJ, Celermajer DS (2006) Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. J Am Coll Cardiol 48:715-720
73. Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JB, Kastelein JJ, Stroes ES (2005) The endothelial glycocalyx: a potential barrier between health and vascular disease. Curr Opin Lipidol 16:507-511
74. Norata GD, Grigore L, Raselli S, Redaelli L, Hamsten A, Maggi F, Eriksson P, Catapano AL (2007) Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies. Atherosclerosis 193:321-327
75. Nordestgaard BG (1996) The vascular endothelial barrierselective retention of lipoproteins. Curr Opin Lipidol 7:269-273
76. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A (2007) Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. Jama 298:299-308
77. Orr AW, Stockton R, Simmers MB, Sanders JM, Sarembock IJ, Blackman BR, Schwartz MA (2007) Matrix-specific p21- activated kinase activation regulates vascular permeability in atherogenesis. J Cell Biol 176:719-727
78. Patel S, Puranik R, Nakhla S, Lundman P, Stocker R, Wang XS, Lambert G, Rye KA, Barter PJ, Nicholls SJ, Celermajer DS (2009) Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins. Atherosclerosis 204:424-428
79. Peng ZY, Zhao SP, He BM, Peng DQ, Hu M (2011) Protective effect of HDL on endothelial NO production: the role of DDAH/ADMA pathway. Mol Cell Biochem 351:243-249
80. Pennathur S, Heinecke JW (2007) Oxidative stress and endothelial dysfunction in vascular disease. Curr Diab Rep 7:257-264
81. Pirillo A, Reduzzi A, Ferri N, Kuhn H, Corsini A, Catapano AL (2011) Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells. Atherosclerosis 214:331-337
82. Riad A, Bien S, Gratz M, Escher F, Westermann D, Heimesaat MM, Bereswill S, Krieg T, Felix SB, Schultheiss HP, Kroemer HK, Tschope C (2008) Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice. Eur J Heart Fail 10:233-243
83. Rouhanizadeh M, Hwang J, Clempus RE, Marcu L, Lassegue B, Sevanian A, Hsiai TK (2005) Oxidized-1-palmitoyl-2-arachidonoyl-snglycero- 3-phosphorylcholine induces vascular endothelial superoxide production: implication of NADPH oxidase. Free Radic Biol Med 39:1512-1522
84. Ruby MA, Goldenson B, Orasanu G, Johnston TP, Plutzky J, Krauss RM (2010) VLDL hydrolysis by LPL activates PPAR-alpha through generation of unbound fatty acids. J Lipid Res 51:2275-2281
85. Rueckschloss U, Galle J, Holtz J, Zerkowski HR, Morawietz H (2001) Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation 104:1767-1772
86. Ryoo S, Bhunia A, Chang F, Shoukas A, Berkowitz DE, Romer LH (2011) OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling. Atherosclerosis 214:279-287
87. Sadowitz B, Maier KG, Gahtan V (2010) Basic science review: statin therapypart I: the pleiotropic effects of statins in cardiovascular disease. Vasc Endovascular Surg 44:241-251
88. Sakamoto N, Ishibashi T, Sugimoto K, Sawamura T, Sakamoto T, Inoue N, Saitoh S, Kamioka M, Uekita H, Ohkawara H, Suzuki K, Teramoto T, Maruyama Y, Takeishi Y (2009) Role of LOX-1 in monocyte adhesion-triggered redox, Akt/eNOS and Ca2+ signaling pathways in endothelial cells. J Cell Physiol 220:706-715
89. Sakurai K, Sawamura T (2003) Stress and vascular responses: endothelial dysfunction via lectin-like oxidized low-density lipoprotein receptor-1: close relationships with oxidative stress. J Pharmacol Sci 91:182-186
90. Sangle GV, Zhao R, Mizuno TM, Shen GX (2010) Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells. Endocrinology 151:4455-4466
91. Sanson M, Auge N, Vindis C, Muller C, Bando Y, Thiers JC, Marachet MA, Zarkovic K, Sawa Y, Salvayre R, Negre-Salvayre A (2009) Oxidized low-density lipoproteins trigger endoplasmic reticulum stress in vascular cells: prevention by oxygen-regulated protein 150 expression. Circ Res 104:328-336
92. Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V (2007) Triglycerides and the risk of coronary heart disease: 10, 158 incident cases among 262, 525 participants in 29 Western prospective studies. Circulation 115:450-458
93. Shin HK, Kim YK, Kim KY, Lee JH, Hong KW (2004) Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD (P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol. Circulation 109:1022-1028
94. Shiu SW, Tan KC, Wong Y, Leng L, Bucala R (2009) Glycoxidized LDL increases lectin-like oxidized low density lipoprotein receptor-1 in diabetes mellitus. Atherosclerosis 203:522-527
95. Silverstein RL, Febbraio M (2009) CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2:re3
96. Sima AV, Stancu CS, Simionescu M (2009) Vascular endothelium in atherosclerosis. Cell Tissue Res 335:191-203
97. Simionescu M (2007) Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler Thromb Vasc Biol 27:266-274
98. Simionescu M, Simionescu N, Silbert JE, Palade GE (1981) Differentiated microdomains on the luminal surface of the capillary endothelium. II. Partial characterization of their anionic sites. J Cell Biol 90:614-621
99. Simionescu M, Popov D, Sima A (2009) Endothelial transcytosis in health and disease. Cell Tissue Res 335:27-40
100. Soran H, Younis NN, Charlton-Menys V, Durrington P (2009) Variation in paraoxonase-1 activity and atherosclerosis. Curr Opin Lipidol 20:265-274
101. Stancu C, Constantinescu E, Sima A (2011) Ceruloplasmin and oxidized LDL colocalize in atherosclerotic lesions of hamster. Cent Eur J Biol 6:23-31
102. Stephen SL, Freestone K, Dunn S, Twigg MW, Homer-Vanniasinkam S, Walker JH, Wheatcroft SB, Ponnambalam S (2010) Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease. Int J Hypertens 2010:646929
103. Sugimoto K, Ishibashi T, Sawamura T, Inoue N, Kamioka M, Uekita H, Ohkawara H, Sakamoto T, Sakamoto N, Okamoto Y, Takuwa Y, Kakino A, Fujita Y, Tanaka T, Teramoto T, Maruyama Y, Takeishi Y (2009) LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells. Cardiovasc Res 84:127-136
104. Sullivan JC, Pollock JS (2006) Coupled and uncoupled NOS: separate but equal? Uncoupled NOS in endothelial cells is a critical pathway for intracellular signaling. Circ Res 98:717-719
105. Tabas I, Williams KJ, Boren J (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116:1832-1844
106. Tavintharan S, Woon K, Pek LT, Jauhar N, Dong X, Lim SC, Sum CF (2011) Niacin results in reduced monocyte adhesion in patients with type 2 diabetes mellitus. Atherosclerosis 215:176-179
107. Tedgui A, Mallat Z (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86:515-581
108. Terasaka N, Yu S, Yvan-Charvet L, Wang N, Mzhavia N, Langlois R, Pagler T, Li R, Welch CL, Goldberg IJ, Tall AR (2008) ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet. J Clin Invest 118:3701-3713
109. Terasaka N, Westerterp M, Koetsveld J, Fernandez-Hernando C, Yvan-Charvet L, Wang N, Sessa WC, Tall AR (2010) ATP-binding cassette transporter G1 and high-density lipoprotein promote endothelial NO synthesis through a decrease in the interaction of caveolin-1 and endothelial NO synthase. Arterioscler Thromb Vasc Biol 30:2219-2225
110. Thum T, Fraccarollo D, Schultheiss M, Froese S, Galuppo P, Widder JD, Tsikas D, Ertl G, Bauersachs J (2007) Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56:666-674
111. Toma L, Stancu CS, Botez GM, Sima AV, Simionescu M (2009) Irreversibly glycated LDL induce oxidative and inflammatory state in human endothelial cells; added effect of high glucose. Biochem Biophys Res Commun 390:877-882
112. Toma L, Stancu CS, Sanda GM, Sima AV (2011) Anti-oxidant and anti-inflammatory mechanisms of amlodipine action to improve endothelial cell dysfunction induced by irreversibly glycated LDL. Biochem Biophys Res Commun 411:202-207
113. Uittenbogaard A, Shaul PW, Yuhanna IS, Blair A, Smart EJ (2000) High density lipoprotein prevents oxidized low density lipoproteininduced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J Biol Chem 275:11278-11283
114. van den Berg BM, Spaan JA, Vink H (2009) Impaired glycocalyx barrier properties contribute to enhanced intimal low-density lipoprotein accumulation at the carotid artery bifurcation in mice. Pflugers Arch 457:1199-1206
115. Van Lenten BJ, Reddy ST, Navab M, Fogelman AM (2006) Understanding changes in high density lipoproteins during the acute phase response. Arterioscler Thromb Vasc Biol 26:1687-1688
116. Van Linthout S, Spillmann F, Graiani G, Miteva K, Peng J, Van Craeyveld E, Meloni M, Tolle M, Escher F, Subasiguller A, Doehner W, Quaini F, De Geest B, Schultheiss HP, Tschope C (2011) Down-regulation of endothelial TLR4 signalling after apo A-I gene transfer contributes to improved survival in an experimental model of lipopolysaccharide-induced inflammation. J Mol Med (Berl) 89:151-160
117. von Eckardstein A, Rohrer L (2009) Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins. Curr Opin Lipidol 20:197-205
118. Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Horkko S, Barnard J, Reynolds WF, Topol EJ, DiDonato JA, Hazen SL (2007) Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 13:1176-1184
119. Wang L, Gill R, Pedersen TL, Higgins LJ, Newman JW, Rutledge JC (2009) Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. J Lipid Res 50:204-213
120. Wheeler-Jones CP (2007) Chylomicron remnants: mediators of endothelial dysfunction? Biochem Soc Trans 35:442-445
121. Yeh HI, Lu CS, Wu YJ, Chen CC, Hong RC, Ko YS, Shiao MS, Severs NJ, Tsai CH (2003) Reduced expression of endothelial connexin37 and connexin40 in hyperlipidemic mice: recovery of connexin37 after 7-day simvastatin treatment. Arterioscler Thromb Vasc Biol 23:1391-1397
122. Yoshimoto R, Fujita Y, Kakino A, Iwamoto S, Takaya T, Sawamura T (2011) The discovery of LOX-1, its ligands and clinical significance. Cardiovasc Drugs Ther
123. Younis N, Sharma R, Soran H, Charlton-Menys V, Elseweidy M, Durrington PN (2008) Glycation as an atherogenic modification of LDL. Curr Opin Lipidol 19:378-384
124. Zalewski A, Macphee C (2005) Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target. Arterioscler Thromb Vasc Biol 25:923-931
125. Zheng XY, Liu L (2007) Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase. J Lipid Res 48:1673-1680
126. Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, Settle M, Schmitt D, Fu X, Thomson L, Fox PL, Ischiropoulos H, Smith JD, Kinter M, Hazen SL (2004) Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 114:529-541
127. Zhu W, Saddar S, Seetharam D, Chambliss KL, Longoria C, Silver DL, Yuhanna IS, Shaul PW, Mineo C (2008) The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity. Circ Res 102:480-487